QCM
NPCE icon

Quantinno Capital Management’s Neuropace NPCE Stock Holding History

Quantinno Capital Management’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$163K Buy
+10,233
New +$165K ﹤0.01% 3360

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Quantinno Capital Management's NPCE Position: Q2 2026 in Review

Quantinno Capital Management opened a new position in Neuropace (NPCE) in Q2 2026: 10,233 shares worth $163K. The stake represents ﹤0.01% of the portfolio and ranks #3360 among its holdings.

113 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

  • Quantinno Capital Management held 10,233 shares of Neuropace worth $163K as of Q2 2026.
  • Neuropace was a new Quantinno Capital Management position in Q2 2026.
  • Neuropace made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #3360 holding.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.